findmyKOL
Clinical trialNCT03992755Active, not recruitingPhase 3Interventional

Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil

SponsorLiquidia Technologies, Inc.Enrollment92Primary Pulmonary Hypertension
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Pulmonary Specialists, Ltd.

    Phoenix, Arizona, United States

  • Banner University Medical Center

    Phoenix, Arizona, United States

  • West Los Angeles Va Healthcare Center

    Los Angeles, California, United States

  • Uc Davis Medical Center

    Sacramento, California, United States

  • Los Angeles Biomedical Research Center

    Torrance, California, United States

  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado, United States

  • University of Florida

    Gainesville, Florida, United States

  • Mayo Clinic-Jacksonville

    Jacksonville, Florida, United States

  • Adventhealth

    Orlando, Florida, United States

  • Emory University School of Medicine

    Atlanta, Georgia, United States

  • Northwestern Medicine, Feinberg School of Medicine

    Chicago, Illinois, United States

  • University of Chicago Medicine

    Chicago, Illinois, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, United States

  • Ochsner Medical Center

    New Orleans, Louisiana, United States

  • Tufts Medical Center

    Boston, Massachusetts, United States

  • Mayo Clinic-Rochester

    Rochester, Minnesota, United States

  • University of New Mexico Health Science Center

    Albuquerque, New Mexico, United States

  • University of Cincinnati Medical Center

    Cincinnati, Ohio, United States

  • Oregon Health and Science Center

    Portland, Oregon, United States

  • Alleghany General Hospital

    Pittsburgh, Pennsylvania, United States

  • Upmc Presbyterian Hospital

    Pittsburgh, Pennsylvania, United States

  • Ut Southwestern Medical Center

    Dallas, Texas, United States

  • Houston Methodist Lung Center

    Houston, Texas, United States

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas, United States

  • Inova Fairfax Medical Campus

    Falls Church, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Jul 2019
Primary completion
31 May 2025
Completion
31 May 2025
Last update posted
29 Jan 2025
Registered enrollment
92
Registry id
NCT03992755

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.